Sign inJoin waitlistJoin the waitlist

Sharon Castellino

Program Director of Leukemia/Lymphoma · Emory University School of Medicine

Credentials: · · · ·

History

Leukemia/Lymphoma Program · Emory University School of Medicine
Present
Winship Cancer Institute at Emory Midtown
Present
St Jude Children's Research Hospital
Present

Research

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
Nature Genetics · 2014 · 383 citations
Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
Blood · 2011 · First of 9 authors · Corresponding · 293 citations
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma
New England Journal of Medicine · 2024 · 205 citations

Kara Kelly
43 papers
FK
Frank Keller
33 papers
Susan Parsons
21 papers
Melissa Hudson
20 papers
Brad Hoppe
16 papers
KM
Kathleen Mccarten
15 papers
Steve Cho
14 papers
TH
Tara Henderson
12 papers
Sarah Milgrom
11 papers
TM
Tamara Miller
11 papers
Jamie Flerlage
10 papers
Smita Bhatia
10 papers · 5 as a resident

Grants

Advancing Novel Therapeutics and Translational Science to Close the Survivorship Gap in Pediatric, Adolescent and Young Adult (AYA) Lymphoma
National Cancer Institute · R50
Contact PI · $536.7K · Emory University
2024–2029
Understanding the Impact of the Affordable Care Act on Cancer Treatment and Outcomes for Adolescents and Young Adults (AYA)
National Cancer Institute · R03
PI · $157.6K · Emory University
2021–2024
Resonance Imaging Trial for Heart bioMarkers (RITHM) in AYA Cancer Survivors
National Cancer Institute · R21
Contact PI · $605.5K · Wake Forest University Health Sciences
2012–2015
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $22.7K · Wake Forest University Health Sciences
2009–2011

Clinical trials

Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)
2015–2026
RITHM - Resonance Imaging Trial for Heart Biomarkers in Adolescent/Young (AYA) Cancer Survivors
Principal investigator · Completed
Wake Forest University Health Sciences
2012–2015
Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain
Study chair · Completed · Early phase 1
Wake Forest University Health Sciences
2006–2010